These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 23255661)

  • 41. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
    Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
    Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viral recognition by Toll-like receptors.
    Barton GM
    Semin Immunol; 2007 Feb; 19(1):33-40. PubMed ID: 17336545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction.
    Shibolet O; Podolsky DK
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1469-73. PubMed ID: 17554134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity.
    Erdman LK; Finney CA; Liles WC; Kain KC
    Mol Biochem Parasitol; 2008 Dec; 162(2):105-11. PubMed ID: 18804125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on the role of innate immune receptors during Brucella abortus infection.
    Oliveira SC; de Almeida LA; Carvalho NB; Oliveira FS; Lacerda TL
    Vet Immunol Immunopathol; 2012 Jul; 148(1-2):129-35. PubMed ID: 21700343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-Like receptors (TLRs) and their ligands.
    Uematsu S; Akira S
    Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toll-like receptors and innate immunity.
    Uematsu S; Akira S
    J Mol Med (Berl); 2006 Sep; 84(9):712-25. PubMed ID: 16924467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toll-like receptors (TLRs) in aquatic animals: signaling pathways, expressions and immune responses.
    Rauta PR; Samanta M; Dash HR; Nayak B; Das S
    Immunol Lett; 2014; 158(1-2):14-24. PubMed ID: 24291116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TLR signalling and association of TLR polymorphism with cardiovascular diseases.
    Sharma S; Garg I; Ashraf MZ
    Vascul Pharmacol; 2016 Dec; 87():30-37. PubMed ID: 27826031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.
    Howell J; Angus P; Gow P; Visvanathan K
    J Gastroenterol Hepatol; 2013 May; 28(5):766-76. PubMed ID: 23432473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent patents in Toll-like receptor pathways and relevance to cancer.
    Kimbro K; Parker S
    Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):189-95. PubMed ID: 19522696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptors and their role in renal pathologies.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The innate immune response during liver inflammation and metabolic disease.
    Bieghs V; Trautwein C
    Trends Immunol; 2013 Sep; 34(9):446-52. PubMed ID: 23668977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptors in gastrointestinal diseases.
    Wagner H
    Dig Dis; 2012; 30 Suppl 1():74-7. PubMed ID: 23075872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Toll-like receptors in microbiota-associated gastrointestinal cancer metastasis.
    Lu Q; Ding H; Li W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S142-9. PubMed ID: 24516050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.